Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

MDxHealth (MDXH) Net Income towards Common Stockholders: 2019-2024

Historic Net Income towards Common Stockholders for MDxHealth (MDXH) over the last 6 years, with Dec 2024 value amounting to -$38.1 million.

  • MDxHealth's Net Income towards Common Stockholders rose 23.68% to -$8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$31.1 million, marking a year-over-year increase of 24.70%. This contributed to the annual value of -$38.1 million for FY2024, which is 11.67% up from last year.
  • According to the latest figures from FY2024, MDxHealth's Net Income towards Common Stockholders is -$38.1 million, which was up 11.67% from -$43.1 million recorded in FY2023.
  • In the past 5 years, MDxHealth's Net Income towards Common Stockholders ranged from a high of -$28.7 million in FY2020 and a low of -$44.0 million during FY2022.
  • Moreover, its 3-year median value for Net Income towards Common Stockholders was -$43.1 million (2023), whereas its average is -$41.7 million.
  • In the last 5 years, MDxHealth's Net Income towards Common Stockholders skyrocketed by 33.50% in 2020 and then crashed by 51.87% in 2022.
  • MDxHealth's Net Income towards Common Stockholders (MRY) stood at -$28.7 million in 2020, then fell by 1.19% to -$29.0 million in 2021, then plummeted by 51.87% to -$44.0 million in 2022, then increased by 2.14% to -$43.1 million in 2023, then rose by 11.67% to -$38.1 million in 2024.
  • Its Net Income towards Common Stockholders was -$38.1 million in FY2024, compared to -$43.1 million in FY2023 and -$44.0 million in FY2022.